The post INJ Price Prediction: Targeting $4.84 Recovery by Year-End Despite Bearish Momentum appeared on BitcoinEthereumNews.com. Caroline Bishop Dec 24, 2025The post INJ Price Prediction: Targeting $4.84 Recovery by Year-End Despite Bearish Momentum appeared on BitcoinEthereumNews.com. Caroline Bishop Dec 24, 2025

INJ Price Prediction: Targeting $4.84 Recovery by Year-End Despite Bearish Momentum

2025/12/25 07:13
4분 읽기
이 콘텐츠에 대한 의견이나 우려 사항이 있으시면 crypto.news@mexc.com으로 연락주시기 바랍니다


Caroline Bishop
Dec 24, 2025 08:30

INJ price prediction points to $4.84 target by December 26 as technical analysis reveals potential bounce from $4.72 support, though bearish momentum persists.

INJ Price Prediction Summary

INJ short-term target (1 week): $4.84 (+8.0% from current $4.48)
Injective medium-term forecast (1 month): $4.70-$4.93 trading range
Key level to break for bullish continuation: $4.93 (upper Bollinger Band resistance)
Critical support if bearish: $4.35 (strong support confluence)

Recent Injective Price Predictions from Analysts

Multiple analysts converge on a cautious but optimistic INJ price prediction for the remainder of December 2025. CoinCodex and MEXC News both project an Injective forecast targeting $4.84 by December 26, representing an 8% recovery from current levels.

The consensus among analysts centers on the critical $4.72 support level, which has held firm despite recent selling pressure. This INJ price target of $4.84 aligns with technical resistance levels and suggests a modest recovery scenario rather than aggressive bullish momentum.

Notably, all recent predictions maintain medium confidence levels, indicating uncertainty in the current market environment. The projected December average of $4.83 suggests sideways consolidation rather than trending behavior, reflecting the challenging technical setup facing Injective.

INJ Technical Analysis: Setting Up for Consolidation

Injective technical analysis reveals a mixed picture with bearish momentum indicators conflicting with oversold conditions. The current RSI reading of 34.38 sits in neutral territory but closer to oversold levels, typically a precursor to short-term bounces.

The MACD histogram at -0.0034 confirms bearish momentum, though the minimal negative reading suggests weakening selling pressure. More significantly, INJ’s position at 0.15 within the Bollinger Bands indicates the price is trading near the lower band at $4.21, historically a zone where bounces occur.

Volume analysis from Binance spot markets shows $4.66 million in 24-hour trading, which is moderate but sufficient to support the predicted recovery move. The daily ATR of $0.41 suggests that the $4.84 target represents approximately two standard deviations of recent volatility, making it a reasonable near-term objective.

Injective Price Targets: Bull and Bear Scenarios

Bullish Case for INJ

The primary bullish scenario for this INJ price prediction targets the $4.84 resistance level, with potential extension to $4.93 if momentum builds. Breaking above the EMA 12 at $4.81 would confirm the recovery narrative and open the path to these higher targets.

For sustained upside, INJ needs to reclaim the SMA 7 at $4.62 first, followed by a decisive break above $4.84. Success here could lead to a test of the SMA 20 at $5.09, representing a 14% gain from current levels.

The Stochastic indicators at extremely low levels (%K: 8.95) support the bounce thesis, as these readings historically precede short-term reversals in Injective’s price action.

Bearish Risk for Injective

The Injective forecast faces significant downside risks if the $4.35 support level fails. This level represents both immediate and strong support confluence, making it critical for maintaining the consolidation scenario.

A break below $4.35 could trigger a retest of the 52-week low at $4.43, with potential extension toward the lower Bollinger Band at $4.21. Such a scenario would invalidate the current recovery prediction and suggest deeper correction ahead.

The bearish momentum reflected in the MACD setup remains the primary risk factor, particularly if accompanied by increasing selling volume.

Should You Buy INJ Now? Entry Strategy

Current levels present a reasonable buy or sell INJ opportunity for traders seeking short-term gains. The optimal entry strategy involves accumulating near current support at $4.48, with additional buying if INJ tests the $4.35 strong support level.

Risk management requires a stop-loss below $4.21 (lower Bollinger Band) to protect against breakdown scenarios. Position sizing should account for the 5% risk from current levels to the stop-loss point.

For conservative investors, waiting for a break above $4.62 (SMA 7) would provide better confirmation of the recovery narrative, though at the cost of missing the initial move.

INJ Price Prediction Conclusion

The INJ price prediction for the remainder of December 2025 targets $4.84 with medium confidence, supported by oversold technical conditions and analyst consensus. The Injective forecast suggests a 7-10 day timeframe for this recovery to materialize.

Key confirmation signals include RSI moving above 40, MACD histogram turning positive, and volume expansion above 6 million daily. Invalidation occurs on a break below $4.35 with sustained bearish momentum.

This INJ price target represents a tactical bounce within a broader consolidation pattern, making it suitable for short-term trading rather than long-term investment positioning. Monitor the $4.72 support level closely as the critical determinant for the prediction’s success.

Image source: Shutterstock

Source: https://blockchain.news/news/20251224-price-prediction-inj-targeting-484-recovery-by-year-end

시장 기회
Injective 로고
Injective 가격(INJ)
$3.441
$3.441$3.441
-0.83%
USD
Injective (INJ) 실시간 가격 차트
면책 조항: 본 사이트에 재게시된 글들은 공개 플랫폼에서 가져온 것으로 정보 제공 목적으로만 제공됩니다. 이는 반드시 MEXC의 견해를 반영하는 것은 아닙니다. 모든 권리는 원저자에게 있습니다. 제3자의 권리를 침해하는 콘텐츠가 있다고 판단될 경우, crypto.news@mexc.com으로 연락하여 삭제 요청을 해주시기 바랍니다. MEXC는 콘텐츠의 정확성, 완전성 또는 시의적절성에 대해 어떠한 보증도 하지 않으며, 제공된 정보에 기반하여 취해진 어떠한 조치에 대해서도 책임을 지지 않습니다. 본 콘텐츠는 금융, 법률 또는 기타 전문적인 조언을 구성하지 않으며, MEXC의 추천이나 보증으로 간주되어서는 안 됩니다.